The Hospital to Home Study: A Pragmatic Trial to Optimize Transitions and Address Disparities in Asthma Care

从医院到家庭研究:优化过渡和解决哮喘护理差异的务实试验

基本信息

  • 批准号:
    10583611
  • 负责人:
  • 金额:
    $ 90.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-01-01 至 2027-12-31
  • 项目状态:
    未结题

项目摘要

Despite evidence-based NIH guidelines for asthma, overall morbidity among children has not significantly decreased. In the US, asthma accounts for >150,000 hospitalizations, >600,000 emergency department visits, and nearly 14 million missed school days annually. Striking socioeconomic and racial inequities persist with under-resourced children incurring a disproportionate share of asthma morbidity. Our long-term goal is to improve health outcomes and reduce disparities in asthma morbidity for all children. Our team will address critical barriers to achieving broad-scale improvements in outcomes for all children hospitalized with asthma in the US, in any setting. This proposal’s overall objective is to improve asthma outcomes by conducting a patient-centered, multicomponent intervention focusing on under-resourced children with asthma at both children’s (ChH) and community hospitals (CH). Intervention components are navigation support, medications in-hand at discharge, primary care provider communication, school-based therapy, and home assessment. Leveraging feedback from stakeholders and building on the telehealth infrastructure, we will utilize a pragmatic effectiveness-implementation trial design to test the overall hypothesis that a refined version of the Hospital-to- Home (H2H) intervention will reduce asthma readmissions over a 12-month follow-up period. The hypothesis will be tested in the following aims. (1): Engage key stakeholders to identify barriers and facilitators for implementation of the components of H2H at children’s (ChH) and community hospitals (CHs). We will conduct qualitative interviews to identify barriers and facilitators and refine each component for optimal implementation. (2): Evaluate health outcomes of the H2H intervention compared to usual care control group for children hospitalized with an asthma exacerbation at ChH and CH sites. We propose a multi-center, randomized trial enrolling 340 caregiver-child (aged 4-12yrs) dyads during hospitalization to a multi-component intervention. (3): Evaluate implementation of each component of the H2H intervention and assess impact of implementation on health outcomes. We will evaluate feasibility, acceptability, and fidelity using mixed-methods to assess variation in implementation of each component across sites and their impact on health outcomes. By focusing on broader implementation at both ChHs and CHs, this innovative proposal has significant implications for improving asthma management and reducing health disparities incurred by under-resourced school-aged children. This proposal is aligned with NIH’s mission to address health disparities and will provide crucial insights in intervention implementation at all types of hospital settings that care for children. Because the hospitalization for children with asthma serves a high-risk population who may otherwise be difficult to reach, identifying the most clinically effective method by which to deliver a preventative health service is urgently needed. This work has the potential to shift current hospitalization clinical practice paradigms from only acute encounters for asthma exacerbations to the broader management of public health prevention.
尽管基于证据的NIH哮喘指南,但儿童的总体发病率并未显着 在美国,哮喘的住院率> 150,000,> 600,000次紧急部门访问, 每年有近1400万个上学日。惊人的社会经济和种族不平等持续存在 资源不足的儿童因哮喘发病率而产生不成比例的份额。我们的长期目标是 改善健康结果并减少所有儿童哮喘发病率的分布。我们的团队将解决 对于所有患有哮喘住院的儿童的结果的关键障碍 美国,在任何情况下。该提议的总体目标是通过进行一次 以患者为中心的多组分干预措施,重点是资源不足的哮喘儿童 儿童(CHH)和社区医院(CH)。干预组件是导航支持,药物 出院时,初级保健提供者沟通,基于学校的治疗和房屋评估。 利用利益相关者的反馈和在远程医疗基础设施上的构建方面,我们将利用务实的 有效实施试验设计,以测试总体假设,即医院到医院的精致版本 家庭(H2H)干预将在12个月的随访期内减少哮喘再入院术。假设 将在以下目标中进行测试。 (1):让主要利益相关者确定障碍和促进者 在儿童(CHH)和社区医院(CHS)上实施H2H的组件。我们将进行 定性访谈以识别障碍和促进者,并完善每个组件以进行最佳实施。 (2):评估H2H干预措施的健康结果与通常的儿童护理对照组 在CHH和CH站点因哮喘加重而住院。我们提出了一个多中心的随机试验 在住院期间,将340个照顾者 - 儿童(4-12岁)纳入多组分干预措施。 (3): 评估H2H干预措施的每个组成部分的实施以及实施的评估影响 健康结果。我们将使用混合方法评估可行性,可接受性和忠诚度来评估 跨站点实施的实施变化及其对健康结果的影响。通过聚焦 关于CHHS和CHS的更广泛实施,这项创新的建议对 改善哮喘管理并减少资源不足的学龄 孩子们。该建议与NIH解决健康差异的使命保持一致,并将提供至关重要的 在所有照顾儿童的医院环境下进行干预实施的见解。因为 哮喘儿童的住院服务为高风险人口服务,否则他们可能难以到达, 确定提供预防卫生服务的最有效的方法是 需要。这项工作有可能将目前的住院临床实践范式从急性转移 哮喘加剧了对公共卫生预防的更广泛管理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kavita Parikh其他文献

Kavita Parikh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kavita Parikh', 18)}}的其他基金

Detecting and Understanding Disparities in Pediatric Safety Events for Hospitalized Children
检测和了解住院儿童儿科安全事件的差异
  • 批准号:
    10661525
  • 财政年份:
    2022
  • 资助金额:
    $ 90.7万
  • 项目类别:
Detecting and Understanding Disparities in Pediatric Safety Events for Hospitalized Children
检测和了解住院儿童儿科安全事件的差异
  • 批准号:
    10450528
  • 财政年份:
    2022
  • 资助金额:
    $ 90.7万
  • 项目类别:

相似国自然基金

阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
  • 批准号:
    82302281
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
  • 批准号:
    22304039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
  • 批准号:
    82300173
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
  • 批准号:
    82360957
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Research and Capacity Building in Antimicrobial Resistance in West Africa
西非抗菌素耐药性研究和能力建设
  • 批准号:
    10685898
  • 财政年份:
    2023
  • 资助金额:
    $ 90.7万
  • 项目类别:
FAACS: Feasibility/Acceptability of Attentional-Control Training in Survivors
FAACS:幸存者注意力控制训练的可行性/可接受性
  • 批准号:
    10458355
  • 财政年份:
    2022
  • 资助金额:
    $ 90.7万
  • 项目类别:
FAACS: Feasibility/Acceptability of Attentional-Control Training in Survivors
FAACS:幸存者注意力控制训练的可行性/可接受性
  • 批准号:
    10684249
  • 财政年份:
    2022
  • 资助金额:
    $ 90.7万
  • 项目类别:
Experimental effects of children's evening media use on circadian phase, sleep, and executive functioning
儿童晚间媒体使用对昼夜节律、睡眠和执行功能的实验影响
  • 批准号:
    10701909
  • 财政年份:
    2022
  • 资助金额:
    $ 90.7万
  • 项目类别:
Validation of Video Administration of a Modified UDSv3 Cognitive Battery
改进的 UDSv3 认知电池的视频管理验证
  • 批准号:
    10370578
  • 财政年份:
    2022
  • 资助金额:
    $ 90.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了